Galapagos

Gilead, Galapagos clear another PhII hurdle for filgotinib, but can they hope to catch up with Novartis’ Cosentyx?
Endpoints
Thu, 09/6/18 - 10:15 am
Gilead Sciences
Galapagos
filgotinib
Novartis
Cosentyx
ankylosing spondylitis
Novartis to Pay as Much as $1 Billion for Rights to Skin Drug
Yahoo/Bloomberg
Thu, 07/19/18 - 09:53 am
Novartis
Galapagos
MorphoSys
MOR106
atopic dermatitis
Galapagos shares are tumbling following disappointing results from a cystic fibrosis trial.
Motley Fool
Fri, 06/29/18 - 11:17 am
Galapagos
AbbVie
cystic fibrosis
Vertex Pharmaceuticals
GLPG2737
Gilead, Galapagos hit goal in psoriatic arthritis phase 2
Fierce Biotech
Thu, 05/31/18 - 09:33 am
Gilead Sciences
Galapagos
filgotinib
psoriatic arthritis
clinical trials
ulcerative colitis
Galapagos Announces ISABELA Ph III Study in Idiopathic Pulmonary Fibrosis
CP Wire
Thu, 04/12/18 - 09:23 pm
Galapagos
GLPG1690
idiopathic pulmonary fibrosis
Galapagos Announces ISABELA Ph III Study in Idiopathic Pulmonary Fibrosis
Thu, 04/12/18 - 08:27 pm
Galapagos
GLPG1690
idiopathic pulmonary fibrosis
3 Great Acquisition Targets for Gilead Sciences -- and 1 Iffy Candidate
Motley Fool
Thu, 02/15/18 - 11:08 am
Gilead Sciences
M&A
Editas
Madrigal Pharmaceuticals
CRISPR Therapeutics
Galapagos
Galapagos tries to avoid being acquired by Gilead
GoinPharma
Mon, 02/12/18 - 04:39 pm
Galapagos
Gilead Sciences
M&A
Galapagos' progress won't rattle CF markets, analysts say
Biopharma Dive
Wed, 01/3/18 - 11:53 pm
Galapagos
cystic fibrosis
GLPG2222
Gilead closer and closer to acquiring Galapagos (€3.96bn)
GoinPharma
Sun, 12/17/17 - 10:27 am
Gilead Sciences
Galapagos
M&A
Don't Count on Gilead Buying Galapagos
Bloomberg
Sat, 12/16/17 - 08:35 am
Gilead Sciences
Galapagos
M&A
Galapagos snags co-promotion rights on filgotinib — just before Gilead’s lock-up pact expires
Endpoints
Thu, 12/14/17 - 09:24 pm
Galapagos
Gilead Sciences
filgotinib
Galapagos continues in Vertex's shadow
BioPharma Dive
Tue, 11/21/17 - 11:30 am
Galapagos
Vertex Pharma
GLPG2222
cystic fibrosis
Vertex Pops As Analyst Questions Whether Rival Has 'Viable Drug'
Investors Business Daily
Sat, 11/4/17 - 05:16 pm
Vertex Pharmaceuticals
Galapagos
cystic fibrosis
Good news from Galapagos’ pulmonary fibrosis product
GoInPharma
Wed, 08/16/17 - 09:42 pm
Galapagos
GLPG1690
idiopathic pulmonary fibrosis
Galapagos spotlights an ‘exciting’ round of PoC data for IPF drug, shares surge
Endpoints
Thu, 08/10/17 - 11:53 am
Galapagos
IPF
GLPG1690
FibroGen
3 Top Biotech Stocks For May
Motley Fool
Thu, 05/11/17 - 06:27 pm
biotech
Galapagos
INSYS Therapeutics
Portola Pharmaceuticals
Forget Incyte: Gilead Sciences Would Be Better Off Buying This Company
Motley Fool
Wed, 01/25/17 - 09:53 am
Gilead Sciences
Incyte
M&A
Galapagos
Galapagos, AbbVie glimpse early progress in search of a cystic fibrosis triple to rival Vertex
Endpoints
Wed, 12/21/16 - 11:10 am
Galapagos
AbbVie
Vertex Pharmaceuticals
cystic fibrosis
GLPG1837
Gilead Sciences Inc.'s Best Moves in 2016
Motley Fool
Thu, 12/15/16 - 12:00 pm
Gilead Sciences
NASH
hepatitis C
filgotinib
Galapagos

Pages